RDY 399 Pill — PINK;BLACK CAPSULE, 19mm — Lansoprazole

No photo available
View full Lansoprazole profile
ImprintRDY / 399
ColourPINK;BLACK
ShapeCAPSULE
Size19
StrengthLANSOPRAZOLE 30 mg
Dosage formCapsule, Delayed Release
ManufacturerMcKesson Corporation dba SKY Packaging
NDC63739-555
Schedule—
Availability—
IngredientsLANSOPRAZOLE[LANSOPRAZOLE]

What does this imprint mean?

The imprint "RDY 399" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Lansoprazole

Uses and warnings

No boxed warning. "Symptomatic response to therapy with lansoprazole does not preclude the presence of gastric malignancy." The label warns that "high-dose, long-term PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine," and of hypomagnesemia, where "serious adverse events include tetany, arrhythmias, and seizures" with prolonged use. Contraindicated only in patients with known severe hypersensitivity to any component of the formulation.

Indicated for short-term treatment of active duodenal ulcer, H. pylori eradication (in combination with amoxicillin, with or without clarithromycin), maintenance of healed duodenal ulcers, treatment of active benign gastric ulcer, healing and risk reduction of NSAID-associated gastric ulcer, treatment of symptomatic GERD and erosive esophagitis, maintenance of healed erosive esophagitis, and treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Lansoprazole

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file e62b20fc-af49-4cde-a44f-37e20e54616a.xml